祥生医疗(688358)披露2024年限制性股票激励计划首次授予部分第一个归属期符合归属条件,10月24日股价上涨4.75%

Core Points - Xiangsheng Medical (688358) closed at 35.27 yuan on October 24, 2025, up 4.75% from the previous trading day, with a total market capitalization of 3.955 billion yuan [1] - The stock opened at 33.65 yuan, reached a high of 36.26 yuan, and a low of 33.65 yuan, with a trading volume of 136 million yuan and a turnover rate of 3.43% [1] Summary of Relevant Sections - The company announced the first vesting period of its 2024 restricted stock incentive plan, with 100,860 shares to be vested, sourced from repurchased A-shares [1] - The initial grant date is set for October 22, 2024, with the vesting period from October 23, 2025, to October 22, 2026 [1] - The company achieved a gross profit of 276.3152 million yuan in 2024, meeting the performance assessment trigger value, resulting in a vesting ratio of 92.11% at the company level [1] - Out of 30 initial grantees, 26 met the vesting conditions, while 3 lost their rights due to resignation and 1 due to failing the assessment [1] - The adjusted grant price is set at 12.50 yuan per share, and the board's compensation and assessment committee, along with the law firm, confirmed compliance with relevant regulations [1]